Lawrence E Eichenfield
Affiliation: Rady Children's Hospital
- Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care ProvidersLawrence F Eichenfield
Departments of Pediatrics and Dermatology, School of Medicine, University of California, San Diego, San Diego, California
Pediatrics 136:554-65. 2015....
- Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxidesLawrence F Eichenfield
Rady Children s Hospital, San Diego and University of California, San Diego, CA, USA
J Drugs Dermatol 12:611-8. 2013..Evaluate the efficacy and safety of adapalene 0.1%-benzoyl peroxide 2.5% gel (adapalene-BPO) in patients 9-11 years old with acne vulgaris.<BR>..
- Evidence-based recommendations for the diagnosis and treatment of pediatric acneLawrence F Eichenfield
Division of Pediatric and Adolescent Dermatology, Rady Children s Hospital, San Diego and Department of Pediatrics, University of California, San Diego, San Diego, California, USA
Pediatrics 131:S163-86. 2013....
- Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled studyLawrence F Eichenfield
Rady Children s Hospital and University of California, San Diego School of Medicine, San Diego, California 92123, USA
Pediatr Dermatol 29:598-604. 2012..04% pump and vehicle in patients aged 9-11 with acne vulgaris. Additional studies are warranted to further characterize the safety and efficacy of TMG 0.04% pump for the treatment of acne in the preadolescent population...
- Atopic dermatitis: epidemiology and pathogenesis updateLawrence F Eichenfield
University of California, San Diego School of Medicine, Rady Children s Hospital, San Diego, CA 92123, USA
Semin Cutan Med Surg 31:S3-5. 2012..These discoveries hold promise for future breakthroughs in the diagnosis and management of AD...
- Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gelLawrence F Eichenfield
Rady Children s Hospital, San Diego, CA, USA
J Drugs Dermatol 11:818-24. 2012..A fixed combination of clindamycin phosphate and benzoyl peroxide (BPO) (clindamycin phosphate 1.2%/BPO 2.5% gel) was evaluated to determine its utility in treating moderate to severe acne in adolescents with skin of color...
- Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled studyLawrence F Eichenfield
Rady Children s Hospital, San Diego, CA 92123 4204, USA
J Drugs Dermatol 10:1382-96. 2011..Topical fixed-combination therapy containing 1% clindamycin as 1.2% clindamycin phosphate (CLNP) and 3% benzoyl peroxide (BPO) is an effective treatment for acne vulgaris (acne)...
- Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safetyLawrence E Eichenfield
University of California, San Diego, USA
J Drugs Dermatol 9:1395-401. 2010..Overall, the adapalene-BPO combination gel provides significantly greater and synergistic efficacy and a fast onset of action compared to the monotherapies and vehicle in young acne patients aged 12-17 years...
- Perspectives on therapeutic options for acne: an updateLawrence F Eichenfield
Rady Children s Hospital, UCSD School of Medicine, San Diego, CA, USA
Semin Cutan Med Surg 29:13-6. 2010..This article provides an overview of the current information on the topical and systemic treatment of acne, including innovative delivery options and new formulations and combinations of existing medications...
- Study of the efficacy and tolerability of 0.04% tretinoin microsphere gel for preadolescent acneLawrence F Eichenfield
Rady Children s Hospital, 8010 Frost St, Suite 602, San Diego, CA 92123, USA
Pediatrics 125:e1316-23. 2010..The goals were to assess the degree of improvement of facial acne after treatment with the 0.04% tretinoin microsphere gel (TMG) among patients 8 to 12 years of age and to assess tolerability and safety...
- A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 yearsLawrence F Eichenfield
Rady Children s Hospital and University of California, San Diego, San Diego, California 92123, USA
Pediatr Dermatol 26:257-61. 2009..This novel CLIN/RA gel for treating acne is tolerable and safe and offers clinicians and teen aged patients a new and efficacious intervention for acne vulgaris...